| DC Field | Value | Language |
|---|
| dc.contributor.author | Botnaru, Victor | |
| dc.contributor.author | Munteanu, Oxana | |
| dc.contributor.author | Rusu, Doina | |
| dc.contributor.author | Onea, Leonid | |
| dc.date.accessioned | 2019-11-28T14:08:36Z | |
| dc.date.available | 2019-11-28T14:08:36Z | |
| dc.date.issued | 2014 | |
| dc.identifier.citation | BOTNARU, Victor, MUNTEANU, Oxana, RUSU, Doina, ONEA, Leonid. Pneumonita interstiţială indusă de terapia antivirală cu interferon. In: Sănătate Publică, Economie şi Management în Medicină. 2014, nr. 5(56), pp. 76-79. ISSN 1729-8687. | en_US |
| dc.identifier.issn | 1729-8687 | |
| dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/7185 | |
| dc.identifier.uri | http://revistaspemm.md/wp-content/uploads/2019/05/cm5_56_2014.pdf | |
| dc.description | Departamentul Medicină Internă, Disciplina Pneumologie/Alergologie,
USMF Nicolae Testemiţanu, Centrul de Diagnostic German, or. Chişinău,
Conferinţa Naţională de Gastroenterologie și Hepatologie cu participare internaţională 20 iunie 2014 Chişinău, Republica Moldova | en_US |
| dc.description.abstract | Pulmonary toxicity is an exceptional but unanticipated complication of interferon (IFN) treatment. Interstitial pneumonitis (IP) can occur at any stage of IFN therapy. Prompt discontinuation of medication is the cornerstone. The severity of pulmonary injury may be associated with the rapid development of IP indicating the necessity of methylprednisolone pulse therapy, followed by low dose prednisolone therapy for a short term. | en_US |
| dc.description.abstract | Развитие лекарственных поражений легких является исключительным и непредвиденным осложнением лечения интерфероном. Интерстициальный пневмонит (ИП) может развиться на любом этапе терапии. Отмена препарата является ключевым фактором успеха. Тяжесть повреждения легких может быть связана с быстрым развитием ИП, указывающим на необходимость пульс-терапии метилпреднизолоном с последуюшим применением небольших доз преднизолона в течение короткого срока. | |
| dc.language.iso | ro | en_US |
| dc.publisher | Asociația Obștească ”Economie, Management și Psihologie în Medicină” din Republica Moldova | en_US |
| dc.subject | hepatitis | en_US |
| dc.subject | interferon | en_US |
| dc.subject | interstitial pneumonitis | en_US |
| dc.subject | corticosteroid therapy | en_US |
| dc.subject.mesh | Lung Diseases, Interstitial--diagnosis | en_US |
| dc.subject.mesh | Lung Diseases, Interstitial--pathology | en_US |
| dc.subject.mesh | Idiopathic Interstitial Pneumonias --diagnosis | en_US |
| dc.subject.mesh | Idiopathic Interstitial Pneumonias--etiology | en_US |
| dc.subject.mesh | Interferons--adverse effects | en_US |
| dc.subject.mesh | Adrenal Cortex Hormones--therapeutic use | en_US |
| dc.title | Pneumonita interstiţială indusă de terapia antivirală cu interferon | en_US |
| dc.title.alternative | Interstitial pneumonitis caused by antiviral therapy with interferon | en_US |
| dc.title.alternative | Интерстициальный пневмонит, вызванный противовирусной терапией интерфероном | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Sănătate Publică, Economie şi Management în Medicină Nr. 5 (56) / 2014
|
